Medigator effortlessly keeps you up to date with the latest immunotherapy treatments

Better shared decision making with more information

Due to the rapid changes in cancer progression and the high cost of immunotherapy, maintaining long-term treatment can be challenging. Medigator provides oncologists with the tools to accurately predict and manage disease progression, evaluate the appropriate timing for medication changes or discontinuation, and identify potential next-phase treatment options. Through ongoing discussions and patient feedback, treatment plans can be adjusted to ensure optimal treatment outcomes and quality of life.

Proactively analyze medical records to
​identify appropriate candidates
​for immunotherapy

Information organized
​on the latest evidence
and clinical guidelines

Stay on track and compile evidence-based immunotherapy guidelines

Organizing information of the latest treatment developments in immunotherapy is challenging. For each immunotherapy, there are hundreds of publications from ongoing clinical trials, updated FDA indications, and clinical guidelines. Medigator offers specialized care plans for all physicians to help them keep on pace.

Recommends targeted immunotherapy plans for early, mid and late-stage cancer patients

Tracks and predicts progression,
prognosis and the efficacy  of immunotherapy

Predict individual risk of immune-related adverse events (irAEs) and manage medications

Request More
​Information